- Home
- MTSI vs ROIV Comparison
MTSI vs ROIV Comparison
Compare MTSI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTSI | ROIV |
|---|---|---|
| Founded | 1950 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5B | 14.1B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | MTSI | ROIV |
|---|---|---|
| Price | $222.10 | $23.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $197.50 | $24.31 |
| AVG Volume (30 Days) | 1.4M | ★ 5.9M |
| Earning Date | 02-05-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $967,258,000.00 | $20,329,000.00 |
| Revenue This Year | $18.17 | N/A |
| Revenue Next Year | $12.77 | $741.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.58 | N/A |
| 52 Week Low | $84.00 | $8.73 |
| 52 Week High | $230.82 | $23.91 |
Technical Indicators
Market Signals| Indicator | MTSI | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 74.06 | 59.82 |
| Support Level | $215.00 | $22.50 |
| Resistance Level | $230.82 | $23.20 |
| Average True Range (ATR) | 10.05 | 0.74 |
| MACD | 3.66 | 0.01 |
| Stochastic Oscillator | 86.08 | 72.84 |
Price Performance
Historical ComparisonAbout MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.